<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">As described earlier, during the SARS-CoV-2 infection, exhaustion of T and NK cells happens. In order to restore these cells, using monoclonal antibodies to block the PD-1/PD-L1 and TIM3 pathways may have beneficial therapeutic effects as well [
 <xref ref-type="bibr" rid="CR49">49</xref>].
</p>
